Factor VIII/von Willebrand factor in glomerular nephropathies

Area of Science:

• Nephrology
• Hematology
• Immunology

Background:

• Glomerulonephritis involves kidney inflammation, potentially impacting coagulation factors.
• Factor VIII/von Willebrand factor (FVIII/vWF) plays a role in hemostasis and may be altered in renal diseases.

Purpose of the Study:

• To investigate plasma and urinary levels of FVIII/vWF in patients with glomerulonephritis.
• To assess the relationship between FVIII/vWF levels and different types of glomerulonephritis, proteinuria, and serum albumin.
• To evaluate the prognostic significance of FVIII/vWF levels in the clinical course of glomerulonephritis.

Main Methods:

• Measured plasma concentrations of factor VIII-related antigen (FVIII:Ag) and factor VIII procoagulant activity (FVIII:C) in 105 glomerulonephritis patients.
• Assessed urinary FVIII:Ag excretion in 72 patients.
• Correlated FVIII/vWF levels with clinical parameters like proteinuria, serum albumin, and disease type.

Main Results:

• Significantly higher median plasma FVIII:Ag levels were found in patients compared to controls.
• Elevated FVIII:Ag was noted in minimal change nephropathy, lupus nephritis, and renal amyloidosis.
• Higher FVIII:Ag levels correlated with nephrotic syndrome and inversely with serum albumin, but not proteinuria extent.
• Urinary FVIII:Ag excretion was variable and not correlated with proteinuria.
• No clear unfavorable association between elevated plasma FVIII:Ag and disease course after 24 months.

Conclusions:

• Plasma and urinary FVIII/vWF levels are frequently altered in glomerulonephritis.
• Elevated FVIII/vWF levels in glomerulonephritis patients do not appear to be a reliable predictor of disease progression.
• Measurement of FVIII/vWF levels in glomerulonephritis requires cautious interpretation regarding clinical course prediction.